Cue Biopharma (CUE) Other Gross PP&E Adjustments (2017 - 2025)
Cue Biopharma's Other Gross PP&E Adjustments history spans 9 years, with the latest figure at -$981000.0 for Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments fell 325.0% year-over-year to -$981000.0; the TTM value through Sep 2025 reached -$981000.0, down 325.0%, while the annual FY2024 figure was -$533000.0, 76.37% up from the prior year.
- Other Gross PP&E Adjustments for Q3 2025 was -$981000.0 at Cue Biopharma, down from -$790000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $5.1 million in Q4 2022 and bottomed at -$4.6 million in Q4 2021.
- The 5-year median for Other Gross PP&E Adjustments is -$981000.0 (2025), against an average of -$1.0 million.
- The largest YoY upside for Other Gross PP&E Adjustments was 211.35% in 2022 against a maximum downside of 2875.48% in 2022.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$4.6 million in 2021, then skyrocketed by 211.35% to $5.1 million in 2022, then plummeted by 143.99% to -$2.3 million in 2023, then skyrocketed by 76.37% to -$533000.0 in 2024, then tumbled by 84.05% to -$981000.0 in 2025.
- Per Business Quant, the three most recent readings for CUE's Other Gross PP&E Adjustments are -$981000.0 (Q3 2025), -$790000.0 (Q2 2025), and $711000.0 (Q1 2025).